The adaptive immune checkpoints BTNL9 and VTCN1 and the innate immune checkpoints CD200 and SIRPA were downregulated in breast tumor tissues while the metabolic immune checkpoints ADORA2A and TDO2 were upregulated in breast tumor tissues (Table S1). Here, VTCN1 is linked to breast neoplasm.